Search
12 hours ago
Introducing The Savills Studio, a great space in the Prudential Tower that is home to the Boston life sciences team, and is available for clients and future clients to use for work or events
Reach out to learn more about how this expert team can help you find and build out your lab space. Featuring: Chris Gorczyca  | Corporate...
Feb 13
Paula Brown Stafford, CEO of the global CRO Allucent, discusses how the company is purpose built to partner with mid-to-small sized biopharma companies on their success
She describes what appealed to her about Allucent when she took the CEO job in July of last year, and highlights the company's regulatory...
Feb 4
One Canal by Breakthrough - Ready for immediate occupancy in Cambridge, MA
Biotech companies looking for office and lab space in the heart of Cambridge, look no further. One Canal by Breakthrough , on First...
Jan 10
Jon Norris shares highlights from the 2024 HSBC Venture Healthcare Full-Year Report
He provides a 2024 year-end recap and 2025 outlook DOWNLOAD THE FULL REPORT #Sponsored
Aug 29, 2024
Wrapping up the summer and looking ahead to biotech's post Labor Day news flow with NYSE's Eric Dimise from Kendall Square
He discusses the sector's IPO activity YTD, what we might expect through the end of the year, and what types of companies have the best...
Aug 27, 2024
Kicking off the Health 2035 Summit in New York with co-hosts Katherine Andersen of HSBC Innovation Banking and Hamid Ghanadan of LINUS
Katherine and Hamid describe today's event that is meant for leaders from across healthcare to discuss and think about where the industry...
Jul 9, 2024
Get to know Allucent -- a full-service, global provider of comprehensive drug development solutions for small and mid-sized biopharmas.
They're on a mission to help bring new therapies to light. Here's how they can help you. Learn more: Allucent.com #sponsored
Jun 12, 2024
One Milestone at Harvard Enterprise Research Campus with biotech legend Arie Belldegrun
Arie Belldegrun discusses Breakthrough Properties, One Milestone at Harvard Enterprise Research Campus, and his take on biotech today....
Jun 12, 2024
One Milestone at Harvard Enterprise Research Campus with Breakthrough Properties' CEO Dan Belldegrun
At an event at Harvard's School of Engineering and Applied Sciences today, Dan Belldegrun describes the future of the Harvard Enterprise...
Jun 4, 2024
Allucent at ASCO 2024
From McCormick Place during #ASCO24, we talk with Brian Abbott, MD, Allucent's Global Head of Oncology, about the latest trends in...
May 23, 2024
CRO Keys to Success: Clinical Pharmacology Modeling and Simulation
Allucent's Katy Moore, PharmD, RPh, describes the importance of 'Clinical Pharmacology Modeling and Simulation' to designing clinical...
May 13, 2024
Visiting the future site of Trinity by Breakthrough in Oxford, UK
Thomas Renn, Head of Europe for Breakthrough Properties, introduces us to this state-of-the-art facility that will encompass 214,000...
Mar 20, 2024
HSBC's Global Capabilities for the Biopharmaceutical Industry
Reece Kresser describes the increasingly global nature of the biopharmaceuticals industry.
Feb 26, 2024
Pfizer Ignite and StudioLabs by Breakthrough Properties announce Partnership
Pfizer Ignite and StudioLabs by Breakthrough Properties are partnering to help biotech entrepreneurs get to work and succeed.
Feb 2, 2024
Talking IPOs and trends in science with NYSE's Eric Dimise
Eric Dimise, Site Lead, Healthcare & Life Sciences Capital Markets at NYSE, shares his thoughts on the optimism reverberating throughout the
Jan 22, 2024
How NYSE is investing in the biotech sector
Head of Healthcare & Life Sciences Capital Markets Johanna Grossman describes the assets that NYSE has available for biotech companies that
Jan 4, 2024
HSBC Venture Healthcare Report
2023 Year-End Recap and 2024 Outlook
.png){kind=logo}
